Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China

Zhou J, Wang Y, Peng J, Tang KJ, Wu J, Chen Y, Xue Z, Wu YL

Lung Cancer: Targets and Therapy 2026, 17:555262

Published Date: 18 February 2026